Fully vaccinated persons' interzonal travel OK'd


The government's pandemic task force has approved the interzonal travel of fully vaccinated individuals, including senior citizens, subject to anti-coronavirus disease (COVID-19) guidelines.

Hundreds of residents from Cebu City who are under A1, A2, A3 priority lists which refer to medical frontliners, senior citizens, and people with comorbidities line up to receive Pfizer vaccines at the University of Cebu on May 19, 2021 (JUAN CARLO DE VELA / MANILA BULLETIN)

In a statement, Presidential Spokesman Harry Roque said the Inter-agency Task Force (IATF) for the Management of Emerging Infectious Diseases allowed such travel subject to the presentation of any of the following:

  • COVID-19 vaccination card issued by legitimate vaccinating establishments
  • Certificate of quarantine completion showing the holder’s vaccination status as may be issued by the Bureau of Quarantine (BOQ)

The presentation of any of the two proof of vaccination shall be sufficient alternatives to any testing requirement that may be required by the local government unit (LGUs) of the traveler's destination.

Travelers are still required to undergo health and exposure screening upon their arrival.

Meanwhile, the intrazonal movement of fully vaccinated senior citizens within areas under General Community Quarantine (GCQ) and Modified General Community Quarantine (MGCQ) shall continue to be allowed.

An individual is considered to be fully vaccinated at least two weeks after receiving the second dose of a two-dose vaccine, or at least two weeks after receiving a single-dose vaccine.

In addition, a fully vaccinated individual must be administered with vaccines that are included in the Emergency Use Authorization (EUA) List or Compassionate Special Permit (CSP) issued by the Philippine Food and Drug Administration (FDA) or Emergency Use Listing (EUL) of the World Health Organization (WHO).

As of June 27, the country has obtained a total of 17,455,470 COVID-19 vaccines including Sinovac (China), Pfizer-BioNTech (USA), AstraZeneca (UK/Sweden), Sputnik V (Russia), and Moderna (USA). All of the said brands are two-dose vaccines.

Recent government data showed that 10,065,414 individuals have been vaccinated against COVID-19 while 2,527,286 people have completed their two doses.